Carcinomatosis from gastrointestinal cancer

Reference

• Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29–42.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Schlag P. Rationale for early postoperative intraperito-neal chemotherapy (EPIC) in patients with advanced gastro-intestinal cancer. Cancer Res 1990;50:5790–4.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH. Heated intraoperative intraperitoneal mito-mycin C and early postoperative intraperitoneal 5-fluorour-acil: Pharmacokinetic studies. Oncology 1998;55:130–8.
   PubMed Web of Science ®Google Scholar
• Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 364–7.
   Google Scholar
• Sadeghi B, Arvieux C, Glehen 0, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multi-centric prospective study. Cancer 2000;88: 358–63.
   Google Scholar
• Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1454–550.
   Google Scholar
• Sampson JA. Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol 1931;VII:423–43.
   Google Scholar
• Weiss L. Metastatic inefficiency: Causes and consequences. Cancer Rev 1986;3:1–24.
   Google Scholar
• Kodera Y, Yamamura Y, Shimizu Y, Toni A, Hirai T, Yasui K, et al. Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma under-going a potentially curative resection. J Surg Oncol 1999;72: 60–5.
   PubMed Web of Science ®Google Scholar
• Zoetmulder FAN. Modelstudies over het colorectale carci-noom. Amsterdam: Rodopi; 1982.
   Google Scholar
• Autio V. The Spread of intraperitoneal infection. Studies with Roentgen contrast medium. Acta Chirurgica Scandinavica 1964;Suppl. 321:5–31.
   Google Scholar
• Meyers MA. Distribution of intra-abdominal malignant seeding: Dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 1973;119:198–206.
   PubMedGoogle Scholar
• Hagiwara A, Sawai K, Sakakura C, Shirasu M, Ohgaki M, Yamasaki J, et al. Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum. Hepatogastroenterology 1998;45:1922–9.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Observations concerning cancer spread with-in the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, ed. Peritoneal Carcino-matosis: Principles of Management. Boston: Kluwer; 1996:79–100.
   Google Scholar
• Carmignani CP, Sugarbaker T, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread. Metastases Reviews (In press).
   Google Scholar
• Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis has a significantly more favorable prognosis than peritoneal mucinous carcino-matosis. Cancer 2001;92:85–91.
   PubMed Web of Science ®Google Scholar
• Archer AG, Sugarbaker PH, Jelinek JS. Radiology of peritoneal carcinomatosis. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer; 1996:263–88.
   Google Scholar
• Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytor-eductive surgery. J Am Coll Surg 1995;181:530–8.
   Google Scholar
• Ottow RT, Steller EP, Sugarbaker PH, Wesley RA, Rosenberg SA. Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models. Cell Immunol 1987; 104:366–76.
   Google Scholar
• Gomez Portilla A, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic factors. World J Surg 1999;23:23–9.
   Google Scholar
• Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 1999;35:413–9.
   PubMed Web of Science ®Google Scholar
• Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994;219:112–9.
   Google Scholar
• Sugarbaker PH. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727–31.
   PubMed Web of Science ®Google Scholar
• Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperito-neal chemotherapy. Cancer 2001;92:71–6.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coeverden F, Zoetmulder FAN. Extensive surgical cytoreduc-tion and intraoperative hyperthermic intraperitoneal chemo-therapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458–63
   PubMed Web of Science ®Google Scholar
• Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26–33.
   PubMed Web of Science ®Google Scholar
• Zoetmulder FAN, Verwall V, Ruth S. NKI/AvL, Amsterdam, Netherlands. Hyperthermic intra peritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol ASCOAbstract: 586.
   Google Scholar
• Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43:515–25.
   Google Scholar
• Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure. Oncology 2000;58:96–107.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Perioperative intraperitoneal chemotherapy in resectable gastric cancer: Surgical responsibilities. In: Rich TAed. Semin Surg Oncol (In press).
   Google Scholar
• Yu W, Whang I, Young C, Averbach A, Sugarbaker PH. Indications for early postoperative intraperitoneal chemo-therapy of advanced gastric cancer: Results of a prospective randomized trial. World J Surg 2001;25:985–90.
   Google Scholar
• Sugarbaker PH, Acherman YIZ, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol 2002;29:51–61.
   Google Scholar
• Sugarbaker PH, Jablonski KA. Prognostic factors of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraper-itoneal chemotherapy. Ann Surg 1995;221:124–32.
   PubMed Web of Science ®Google Scholar
• Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999;6:790–6.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Bayon L, Sugarbaker PH, Gonzalez-Moreno S, Vazquez VL, Alves S, Moran B. Initiation of a program in peritoneal surface malignancy. In: Sugarbaker PH, ed. Management of Peritoneal Surface Malignancy. Surg Oncol Clin N Am 2003;12:741–53.
   Google Scholar
• McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyper-thermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001;27:65–73.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (Editorial) Carcinomatosis, is cure an option? J Clin Oncol 2003;21:762–4.
   PubMed Web of Science ®Google Scholar